IMMUNITYBIO INC (IBRX) — institutional ownership
436 funds reported holding IMMUNITYBIO INC in their latest 13F filings, worth $2.07B in total (CUSIP 45256X103).
Largest holders
- BlackRock, Inc. (BLK) — $298M
- STATE STREET CORP (STT, STT-PG) — $187M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $156M
- VANGUARD CAPITAL MANAGEMENT LLC — $137M
- D. E. Shaw & Co., Inc. — $101M
- TWO SIGMA INVESTMENTS, LP — $97.2M
- GEODE CAPITAL MANAGEMENT, LLC — $86.2M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $73.3M
- VANGUARD GROUP INC — $64.9M
- CITADEL ADVISORS LLC — $49.7M
Famous investors holding it
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Two Sigma portfolio (Two Sigma Investments)
- Ken Griffin portfolio (Citadel Advisors)
- Izzy Englander portfolio (Millennium Management)
- Renaissance Technologies portfolio (Renaissance Technologies)
Insider buying and selling at IMMUNITYBIO INC
Who owns the most IBRX stock?
The largest institutional holders in the latest 13F filings are BlackRock, Inc. (BLK) ($298M), STATE STREET CORP (STT, STT-PG) ($187M), VANGUARD PORTFOLIO MANAGEMENT LLC ($156M).
How many funds own IBRX?
436 funds reported holding it, worth $2.07B in total.